You are here

Home

Clinical Trials: Vascular Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, January 13, 2020 - 12:00
Intranasal Human Milk for Intraventricular Hemorrhage
Condition:   Intraventricular Hemorrhage
Intervention:   Other: Human breast milk
Sponsors:   The Hospital for Sick Children;   MOUNT SINAI HOSPITAL
Not yet recruiting
Posted: Thursday, October 31, 2019 - 12:00
Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
Conditions:   Type 2 Diabetes;   Peripheral Vascular Disorder Due to Diabetes Mellitus
Interventions:   Drug: Liraglutide+standard-of-care treatment;   Other: standard-of-care treatment
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting
Posted: Friday, October 11, 2019 - 12:00
IpsiHand System for Rehabilitation of the Arm and Hand After Stroke
Conditions:   Stroke;   Hemiparesis
Intervention:   Device: IpsiHand Treatment
Sponsors:   Columbia University;   Neurolutions, Inc.
Not yet recruiting
Posted: Thursday, September 26, 2019 - 12:00
PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS
Condition:   Diabetic Foot Ulcer
Intervention:   Drug: Corlicyte
Sponsor:   University of Colorado, Denver
Not yet recruiting
Posted: Friday, September 20, 2019 - 12:00
Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke
Condition:   Acute Ischemic Stroke
Intervention:   Biological: UMC119-06
Sponsor:   Meridigen Biotech Co., Ltd.
Not yet recruiting
Posted: Wednesday, September 18, 2019 - 12:00
Effect of Different Transplantation Time for Mesenchymal Stem Cells(MSCs) of Cerebral Infarction Patients
Conditions:   Infarction, Middle Cerebral Artery;   Infarction, Anterior Cerebral Artery;   Cerebral Infarction;   Stroke, Ischemic;   Acute Stroke
Interventions:   Biological: human umbilical cord mesenchymal stem cells;   Biological: Placebo;   Other: standardized treatment
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Thursday, September 12, 2019 - 12:00
An Open-labeled Phase II Study to Evaluate the Efficacy and Safety of GXNPC-1 (Autologous Adipose-derived Stem Cells) in Patients With Chronic Stroke
Condition:   Chronic Stroke
Intervention:   Drug: GXNPC1
Sponsor:   Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Posted: Wednesday, August 14, 2019 - 12:00
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Recruiting
Posted: Friday, August 9, 2019 - 12:00
MCRcI® Stem Cell Treatment for Diffuse Coronary Artery Disease
Condition:   Coronary Artery Disease
Intervention:   Biological: MCRcI® stem cells
Sponsors:   Honya Medical Inc;   Chang Gung Memorial Hospital
Recruiting
Posted: Thursday, August 8, 2019 - 12:00
MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction)
Condition:   Myocardial Infarction
Intervention:   Biological: MiSaver®
Sponsors:   Honya Medical Inc;   Chung Shan Medical University
Recruiting

Pages